Literature DB >> 6801513

Epidemiology of penicillinase-producing Neisseria gonorrhoeae infections: analysis by auxotyping and serogrouping.

H H Handsfield, E G Sandström, J S Knapp, P L Perine, W L Whittington, D E Sayers, K K Holmes.   

Abstract

Auxotyping and serogrouping by coagglutination were used to characterize penicillinase-producing Neisseria gonorrhoeae and penicillinase-negative isolates from the state of Washington, Shreveport (Louisiana), and the Far East. Fifty-four of 75 penicillinase-producing isolates (72 per cent) from Washington required proline for growth and were serogroup W-l (Pro-1), the predominant type of penicillinase-producing strains in the Philippines; none of 86 penicillinase-negative isolates from Washington was Pro-1 (P less than 0.0001). All 38 penicillinase-producing isolates from Shreveport required proline and were serogroup W-11 (Pro-11); five of 26 penicillinase-negative isolates (19 per cent) from Shreveport were also Pro-11 (P less than 0.0001) but had antigenic specificities within serogroup W-ll that distinguished them from the penicillinase-producing isolates. We conclude that the Washington and Shreveport outbreaks resulted from the spread of imported strains rather than transmission of penicillinase-encoding plasmids to indigenous gonococci. The Shreveport outbreak involved a single strain of penicillinase-producing N, gonorrhoeae and probably originated from a common source, whereas several types were involved in the multiple-source Washington outbreak, indicating repeated introduction of new strains.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6801513     DOI: 10.1056/NEJM198204223061602

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  32 in total

Review 1.  Antimicrobial resistance--pharmacological solutions.

Authors:  E Rubinstein
Journal:  Infection       Date:  1999       Impact factor: 3.553

2.  Genomic fingerprinting of penicillinase-producing strains of Neisseria gonorrhoeae in Valencia, Spain.

Authors:  M A Dasi; J M Nogueira; J J Camarena; C Gil; R García-Verdú; J L Barberá; J Barberá
Journal:  Genitourin Med       Date:  1992-06

3.  Comparative trial of single-dose ciprofloxacin and ampicillin plus probenecid for treatment of gonococcal urethritis in men.

Authors:  R E Roddy; H H Handsfield; E W Hook
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

4.  Sexually transmitted diseases in the USA: temporal trends.

Authors:  Sevgi O Aral; Kevin A Fenton; King K Holmes
Journal:  Sex Transm Infect       Date:  2007-07       Impact factor: 3.519

5.  Plasmid profile of penicillinase-producing Neisseria gonorrhoeae in Greece.

Authors:  A Sima; L Mavrommati
Journal:  Eur J Epidemiol       Date:  1986-09       Impact factor: 8.082

6.  Auxotypes, plasmid contents, and serovars of gonococcal strains (PPNG and non-PPNG) from Jamaica.

Authors:  J R Dillon; M Carballo; S D King; A R Brathwaite
Journal:  Genitourin Med       Date:  1987-08

7.  Genotypes and phenotypes of beta lactamase producing strains of Neisseria gonorrhoeae from African countries.

Authors:  E S Falk; S M Bygdeman; N K Birkeland; B Bjorvatn; I Kallings; E G Sandström
Journal:  Genitourin Med       Date:  1988-08

8.  Serological classification in relation to auxotypes, plasmid contents, and susceptibilities to antimicrobials of PPNG and non-PPNG strains isolated in Greece.

Authors:  G Tzanakaki; L Mavrommati; E Tzelepi; S Kolyva; E Fragouli
Journal:  Genitourin Med       Date:  1989-06

9.  Isolation of Neisseria gonorrhoeae on selective and nonselective media in a sexually transmitted disease clinic.

Authors:  P Bonin; T T Tanino; H H Handsfield
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

10.  Evaluation of difloxacin in the treatment of uncomplicated urethral gonorrhea in men.

Authors:  B L Smith; M Cummings; S Benes; K Draft; W M McCormack
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.